Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

GENETIC(4)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 14
Phase 22

Trial Status

Recruiting3
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
Diabetic Retinopathy
PrincipalinvestigatorStart date: 2024-03-28
NCT06492876Phase 1/2Recruiting
Gene Therapy for DME
Diabetic Macular Edema
PrincipalinvestigatorStart date: 2023-11-15
NCT06492863Phase 1/2Recruiting
Gene Therapy(FT-003) for Wet AMD
Neovascular Age-related Macular Degeneration
PrincipalinvestigatorStart date: 2023-08-15
NCT05916391Phase 1Recruiting
Gene Therapy for Diabetic Macular Edema
Diabetic Macular Edema
PrincipalinvestigatorStart date: 2023-05-19
NCT05611424Phase 1Not Yet Recruiting
Gene Therapy for Wet AMD
Neovascular Age-related Macular Degeneration
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Tianjin Medical University Eye Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hamid Ahmadieh, MD

Ophthalmic Research Center of Shaheed Beheshti Medical University

Moderately Similar
11 trials

Shared therapeutic areas:

Diabetic RetinopathyNeovascular Age-related Macular DegenerationDiabetic Macular Edema
Similarity Score30%

Pablo Velazquez-Martin, MD

Kodiak Sciences Inc

Related
10 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic Retinopathy
Similarity Score20%

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en México

Related
8 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic Retinopathy
Similarity Score20%

Hanyi Min

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration

Worked with same sponsors:

Frontera TherapeuticsPeking Union Medical College Hospital+3 more
Collaborated on 1 trial
Similarity Score14%

Hanyi Min, Professor

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema

Worked with same sponsors:

Frontera TherapeuticsPeking Union Medical College Hospital+2 more
Collaborated on 1 trial
Similarity Score14%

Guangming Wan

The First Affiliated Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration

Worked with same sponsors:

Frontera TherapeuticsPeking Union Medical College Hospital+3 more
Collaborated on 1 trial
Similarity Score14%

Guangming Wan, Professor

The First Affiliated Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema

Worked with same sponsors:

Frontera TherapeuticsPeking Union Medical College Hospital+2 more
Collaborated on 1 trial
Similarity Score14%

Peirong Lu, Professor

The First Affiliated Hospital of Soochou University

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration

Worked with same sponsors:

Frontera TherapeuticsPeking Union Medical College Hospital+3 more
Collaborated on 1 trial
Similarity Score14%

Thomas A. Ciulla, MD

Midwest Eye Institute

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema
Similarity Score10%

Louis Glazer, MD

Vitreo-Retinal Associates

Related
1 trials

Shared therapeutic areas:

Diabetic Macular Edema
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06478407PrincipalInvestigator

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Diabetic Retinopathy
Unknown
NCT06492876Phase 1/2PrincipalInvestigator

Gene Therapy for DME

Diabetic Macular Edema
Recruiting
NCT06492863Phase 1/2PrincipalInvestigator

Gene Therapy(FT-003) for Wet AMD

Neovascular Age-related Macular Degeneration
Recruiting
NCT05916391Phase 1PrincipalInvestigator

Gene Therapy for Diabetic Macular Edema

Diabetic Macular Edema
Recruiting
NCT05611424Phase 1PrincipalInvestigator

Gene Therapy for Wet AMD

Neovascular Age-related Macular Degeneration
Not Yet Recruiting

All 5 trials loaded